SofiaVerstraeteMD
Pediatric Gastroenterology • San Francisco, CAPediatric Inflammatory Bowel Disease Gastroenterology
Physician
Dr. Verstraete is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th St
San Francisco, CA 94143Phone+1 415-353-2813Fax+1 415-353-2474
Education & Training
University of California (San Francisco)Fellowship, Pediatric Gastroenterology, 2012 - 2016- University of California (San Francisco)Fellowship, Pediatric Gastroenterology, 2016
University of Miami/Jackson Health SystemResidency, Pediatrics, 2009 - 2012
Universidad Nacional Autonoma de MexicoClass of 2008
Certifications & Licensure
CA State Medical License 2012 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
Clinical Trials
- Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD) Start of enrollment: 2021 Aug 13
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) Start of enrollment: 2022 Apr 18
Roles: Principal Investigator
- A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) Start of enrollment: 2022 Apr 30
Roles: Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Travel Time to Treating Center is Associated With Diagnostic Delay in Pediatric Inflammatory Bowel Disease.Joi F McLaughlin, Tiffany Linville, Traci W Jester, Tuvia A Marciano, Farrah Lazare
Clinical Gastroenterology and Hepatology. 2024-08-23 - 2 citationsToxigenic Clostridium perfringens Isolated from At-Risk Paediatric Inflammatory Bowel Disease Patients.James Kuo, Jasmina Uzunovic, Amanda Jacobson, Michelle Dourado, Sarah Gierke
Journal of Crohn's & Colitis. 2024-08-06 - 3 citationsReal-world effectiveness of ustekinumab and vedolizumab in TNF-exposed pediatric patients with ulcerative colitis.Perseus V Patel, Amy Zhang, Balu Bhasuran, Vignesh G Ravindranath, Melvin B Heyman
Journal of Pediatric Gastroenterology and Nutrition. 2024-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
